AUTUMN HALL: Open Payments
NPI 1306396809 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,095 in 63 payments from 17 companies in 2025. Trend: 2023 $805 · 2024 $1,316 · 2025 $1,095
Food & beverage: $1,095
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $181 |
| Novo Nordisk Inc | 16 | $175 |
| AstraZeneca Pharmaceuticals LP | 2 | $159 |
| Dexcom, Inc. | 5 | $82 |
| Lilly USA, LLC | 3 | $53 |
| Astellas Pharma US Inc | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $39 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Exact Sciences Corporation | 2 | $28 |
Products named: JARDIANCE, VRAYLAR, AIRSUPRA, Dexcom G6 Transmitter, Rybelsus, Ozempic, Veozah, INSPIRE.
Industry payments across TX — which companies pay providers there.
